Affiliation:
1. Department of Cardiology; Renmin Hospital of Wuhan University; Wuhan China
2. Department of Cardiology, The Third Xiangya Hospital; Central South University; Changsha China
3. Institute of Model Animal of Wuhan University; Wuhan China
4. Basic Medical School; Wuhan University; Wuhan China
Funder
National Science and Technology Support Project
National Natural Science Foundation of China
Key Collaborative Project of the National Natural Science Foundation
National Key Research and Development Program
Key Project of the National Natural Science Foundation
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Reference123 articles.
1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2017
2. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease;European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity;J Hepatol,2016
3. Should we undertake surveillance for HCC in patients with NAFLD;Younes;J Hepatol,2018
4. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence;Lonardo;J Hepatol,2018
5. Non-alcoholic fatty liver disease (NAFLD): summary of nice guidance;Glen;BMJ,2016
Cited by
103 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献